Cargando…

Response of primary tumor and lymph node in non-small cell lung cancer after neoadjuvant immunotherapy: a pooled analysis

The good pathological response of primary tumors (PTs) to neoadjuvant immunotherapy has been acknowledged in non-small cell lung cancer (NSCLC), however, it remains unclear whether neoadjuvant immunotherapy shows consistent effects in metastatic lymph nodes (LNs). We compared the pathological respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Wen-Yu, Zhao, Ze-Rui, Chen, Si, Yu, Hui, Lin, Yao-Bin, Wang, Yi-Zhi, Long, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478833/ https://www.ncbi.nlm.nih.gov/pubmed/36109085 http://dx.doi.org/10.1136/jitc-2022-005160

Ejemplares similares

Different In Situ Immune Patterns between Primary Tumor and Lymph Node in Non-Small-Cell Lung Cancer: Potential Impact on Neoadjuvant Immunotherapy
por: Ye, Zheng-Hao, et al.
Publicado: (2022)

Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients?
por: van Zeeland, Marianne, et al.
Publicado: (2020)

Deep decision support for lymph node metastatic risk evaluation
por: Marostica, Eliana, et al.
Publicado: (2020)

Oncologic Benefit of Adjuvant Therapy in Lateral Pelvic Lymph Node Metastasis following Neoadjuvant Chemoradiotherapy and Lateral Pelvic Lymph Node Dissection
por: Jiang, Yu-Juan, et al.
Publicado: (2022)

Pathological Responses of the Primary Tumor and Locoregional Lymph Nodes After Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Cancer
por: Huang, Shu Jie, et al.
Publicado: (2022)

Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer
por: Zhao, Ze-Rui, et al.
Publicado: (2021)

Radiomic models for lymph node metastasis prediction in cervical cancer: can we think beyond sentinel lymph node?
por: Bizzarri, Nicolò, et al.
Publicado: (2021)

Lymph node targeting for immunotherapy
por: Wang, Y., et al.
Publicado: (2023)

Pan-Immune-Inflammatory Value in Patients with Non-Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy
por: Zhai, Wen-Yu, et al.
Publicado: (2023)

Mesenteric lymph nodes at the center of immune anatomy
por: Macpherson, Andrew J., et al.
Publicado: (2006)

Impact factors of lymph node retrieval on survival in locally advanced rectal cancer with neoadjuvant therapy
por: Mei, Shi-Wen, et al.
Publicado: (2020)

Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer
por: Chen, Jia-Nan, et al.
Publicado: (2020)

Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020)

Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma
por: Rakislova, Natalia, et al.
Publicado: (2017)

Moving beyond the T cell synapse for combination neoadjuvant immunotherapy in head and neck cancer
por: Bell, R. Bryan, et al.
Publicado: (2022)

Neoadjuvant immunotherapy for resectable esophagal squamous cell carcinoma: An ace up the sleeve
por: Zhou, Qing, et al.
Publicado: (2023)

Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
por: Mitchell, Dana, et al.
Publicado: (2019)

Robot assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor
por: Cost, Nicholas G.
Publicado: (2013)

Defining the role of lymph node metastasis in systemic breast cancer evolution
por: Naxerova, Kamila
Publicado: (2020)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Single-direction VATS left lower lobectomy and lymph node dissection after neoadjuvant chemotherapy combined with immunotherapy: a case report
por: Lin, Jihong, et al.
Publicado: (2021)

Ultrasound radiomics based on axillary lymph nodes images for predicting lymph node metastasis in breast cancer
por: Tang, Yu-Long, et al.
Publicado: (2023)

Support Vector Machines Model of Computed Tomography for Assessing Lymph Node Metastasis in Esophageal Cancer with Neoadjuvant Chemotherapy
por: Wang, Zhi-Long, et al.
Publicado: (2017)

Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy
por: He, Ao, et al.
Publicado: (2023)

The prognostic relevance of examined lymph nodes for accurate staging of resected pancreatic adenocarcinoma
por: Zaharia, Claudia, et al.
Publicado: (2022)

Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non–small-cell lung cancer: a case report
por: Liu, Yunpeng, et al.
Publicado: (2021)

Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Clinically Node-Positive Breast Cancer after Neoadjuvant Chemotherapy: A Meta-Analysis
por: Fu, Jian-Fei, et al.
Publicado: (2014)

Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled Analysis
por: Alamoodi, Munaser, et al.
Publicado: (2023)

Endoscopic Ultrasound Fine-Needle Biopsy May Contribute to the Diagnosis of Malignant Lymph Nodes
por: Takenaka, Mamoru, et al.
Publicado: (2020)

Benign lymph node microenvironment is associated with response to immunotherapy
por: Toki, Maria I, et al.
Publicado: (2020)

Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy
por: Kim, Hyunhee, et al.
Publicado: (2021)

Lateral lymph node dissection and urogenital function with and without neoadjuvant treatment
por: Bustamante-Lopez, Leonardo Alfonso, et al.
Publicado: (2022)

Comments on "Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients"
por: Sindoni, Alessandro, et al.
Publicado: (2016)

Cancer stem cells promote lymph nodes metastasis of breast cancer by reprogramming tumor microenvironment
por: Li, Lin, et al.
Publicado: (2023)

Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer
por: Wang, Mengshen, et al.
Publicado: (2020)

The Evolving Role of Marked Lymph Node Biopsy (MLNB) and Targeted Axillary Dissection (TAD) after Neoadjuvant Chemotherapy (NACT) for Node-Positive Breast Cancer: Systematic Review and Pooled Analysis
por: Swarnkar, Parinita K., et al.
Publicado: (2021)

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration
por: Yu, Yue, et al.
Publicado: (2016)

Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy
por: Cao, Xiao-Shan, et al.
Publicado: (2016)

Optimal Lymph Node Yield for Survival Prediction in Rectal Cancer Patients After Neoadjuvant Therapy
por: Lin, Yu-Min, et al.
Publicado: (2021)

Factors Associated with Axillary Lymph Node Status in Clinically Node-Negative Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Yu, Chi-Chang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tnrp4g8pvf9bkrniu0dk9ee2qu